Department of Food Science, Madison 53706.
School of Medicine and Public Health, Madison 53706.
J Dairy Sci. 2018 Aug;101(8):6823-6834. doi: 10.3168/jds.2017-14338. Epub 2018 May 16.
A growing concern around the world is the number of people who are suffering from food protein allergies. One potential approach to decrease protein allergenicity is to block IgE-binding epitopes of the protein allergen by attachment of polysaccharides via the Maillard reaction (i.e., glycation). Protein glycation has been extensively studied to modify various functional properties. We wanted to examine whether glycates could reduce IgE binding in patients with cow milk protein allergy and to explore how the size (molar mass; M) of the polysaccharide affects this IgE-binding capacity. Glycation was performed using the initial step of the Maillard reaction performed in aqueous solutions. The specific goal of this study was to reduce the IgE-binding capacity of whey protein isolate (WPI) through glycation with dextran (DX). Blood sera were obtained from 8 patients who had been diagnosed with cow milk protein allergy, and a composite sera sample was used for IgE-binding analysis by the ImmunoCap (Phadia, Uppsala, Sweden) method. The WPI was glycated with DX of M ranging from 1 to 2,000 kDa, and the M of purified glycates was determined using size-exclusion chromatography coupled with multiangle laser light scattering. The WPI to DX molar ratios in the glycates made from DX that had M values of 1, 3.5, 10 (G10), 150, 500, and 2,000 kDa were 1:4, 1:3, 1:2, 1:1.5, 1:1, and 1:1, respectively. With the increase in the M of DX, there was an increase in the M values of the corresponding glycates but a decrease in the number of bound DX. The WPI-DX glycates had lower whey protein IgE-binding capacity than native WPI, with the lowest IgE-binding capacity obtained in the G10 glycate. The DX binding ratios and morphology results from atomic force microscopy images suggested that glycation of WPI with small-M DX resulted in extensive protein surface coverage, probably due to the attachment of up to 4 DX molecules per whey protein. The lower IgE binding of the G10 glycate was likely due to greater steric hindrance (or a physical barrier) at the surface of the protein. In summary, our results demonstrate that glycating WPI with DX via Maillard reaction can potentially be used to decrease the allergenicity of whey protein.
人们越来越关注食物蛋白过敏人群的数量。通过美拉德反应(即糖化)将多糖附着在蛋白质过敏原上,从而阻断 IgE 结合表位,这是一种降低蛋白质变应原性的潜在方法。人们已经广泛研究了蛋白质糖化以改变各种功能特性。我们想研究糖化物是否可以减少牛乳蛋白过敏患者的 IgE 结合,并探讨多糖的大小(摩尔质量;M)如何影响这种 IgE 结合能力。糖化是在水溶液中进行美拉德反应的初始步骤来完成的。本研究的具体目标是通过用葡聚糖(DX)糖化乳清蛋白分离物(WPI)来降低 IgE 结合能力。从被诊断患有牛乳蛋白过敏的 8 名患者中获得血清,并使用 ImmunoCap(Phadia,瑞典乌普萨拉)方法通过 IgE 结合分析用复合血清样本进行分析。用摩尔质量(M)为 1 至 2000 kDa 的 DX 将 WPI 糖化,并用尺寸排阻色谱法与多角度激光散射法测定纯化糖化物的 M。M 值为 1、3.5、10(G10)、150、500 和 2000 kDa 的 DX 制成的糖化物中 WPI 与 DX 的摩尔比分别为 1:4、1:3、1:2、1:1.5、1:1 和 1:1。随着 DX 的 M 值增加,相应糖化物的 M 值增加,但结合的 DX 数量减少。WPI-DX 糖化物的乳清蛋白 IgE 结合能力低于天然 WPI,其中 G10 糖化物的 IgE 结合能力最低。DX 结合比和原子力显微镜图像的形态结果表明,用小 M 值的 DX 糖化 WPI 导致蛋白质表面广泛覆盖,可能是由于每个乳清蛋白附着多达 4 个 DX 分子。G10 糖化物的 IgE 结合较低可能是由于蛋白质表面的空间位阻(或物理障碍)更大。总之,我们的结果表明,通过美拉德反应用 DX 糖化 WPI 可能可用于降低乳清蛋白的变应原性。